HKUST-developed blood test (IMAGE) Hong Kong University of Science and Technology Caption The HKUST-developed blood test can achieve exceptionally accurate classification of Alzheimer’s disease (accuracy >96%) and mild cognitive impairment (accuracy >87%). This surpasses the performance of certain existing blood tests for Alzheimer’s disease that use Aβ42/40, NfL, or p-Tau181 biomarkers. Credit HKUST Usage Restrictions None License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.